No intervention (observational study): No intervention (observational study)
Study summary
Asthma is one of the most prevalent chronic respiratory diseases in children, and accurate phenotyping and disease monitoring remain challenging in routine clinical practice. This observational cohort study aims to investigate the clinical value of multimodal tongue and pulse information in the syndrome diagnosis and phenotypic characterization of pediatric asthma. Children aged 5-18 years with a confirmed diagnosis of asthma will be enrolled at Shanghai Children's Medical Center and followed in routine outpatient care.
Standardized tongue images and pulse wave data will be collected using validated acquisition devices during visits when lung function testing is performed. Quantitative features extracted from tongue and pulse data will be integrated with clinical information, including asthma stage, lung function parameters, eosinophil counts, allergic sensitization status, and Asthma Control Questionnaire-5 (ACQ-5) scores. The primary objective is to evaluate the associations between tongue-pulse multimodal features and asthma clinical stages and pulmonary function. Secondary objectives include exploring their relationships with airway inflammation and asthma control status.
This study seeks to establish a non-invasive, objective, and quantifiable approach to asthma phenotyping, providing evidence for integrating traditional diagnostic features with modern clinical data to support precision management of pediatric asthma.
Eligibility
Sex
ALL
Min age
5 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
* Children aged 5 to 18 years.
* Clinically diagnosed asthma according to established pediatric asthma guidelines.
* Receiving routine outpatient follow-up at Shanghai Children's Medical Center.
* Able to cooperate with tongue image acquisition and pulse wave data collection.
* Able to perform pulmonary function testing when clinically indicated.
* Written informed consent obtained from parents or legal guardians, with assent from the child when appropriate.
Exclusion Criteria:
* Presence of other chronic respiratory diseases (e.g., cystic fibrosis, bronchiectasis, primary ciliary dyskinesia).
* Congenital cardiopulmonary malformations or significant cardiovascular disease.
* Acute respiratory infection or fever at the time of data collection.
* Severe systemic diseases or immunodeficiency that may affect study participation.
* Inability to comply with study procedures or incomplete clinical data.
Primary outcome measure(s)
Association Between Tongue-Pulse Multimodal Features and Pulmonary Function in Pediatric Asthma — During routine outpatient visits at baseline and follow-up when pulmonary function testing is performed (up to 12 months) The primary outcome is the correlation between quantitative tongue-pulse multimodal features and pulmonary function parameters in children with asthma. Tongue images and pulse wave signals are collected during routine outpatient visits and analyzed to extract quantitative features, such as color, texture, and shape parameters of the tongue images, as well as pulse rate and amplitude from the pulse wave signals. Pulmonary function parameters, including FEV₁ (Forced Expiratory Volume in 1 second, measured in liters), FEV₁/FVC (Forced Expiratory Volume in 1 second to Forced Vital Capacity ratio, measured as a percentage), and airway resistance indices (R5 and R20, measured in cm H₂O/L/s), are obtained as part of standard clinical care. Correlation and regression analyses will be performed to evaluate the correlation between tongue-pulse features and pulmonary function status. Time Frame: During routine outpatient visits at baseline and follow-up when pulmonary function testing is perform
Trial sites (1)
Facility
City
Region
Status
Shanghai Children's Medical Center
Shanghai
China
Recruiting
More Shanghai Children's Medical Center trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.